SI
CLB icon

Sprott Inc’s Core Laboratories CLB Stock Holding History

Sprott Inc’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,359
Closed -$295K – 137
2023
Q1 		$295K Sell
13,359
-267
-2% -$6.25K 0.02% 110
2022
Q4 		$276K Sell
13,626
-70
-0.5% -$1.36K 0.02% 116
2022
Q3 		$185K Sell
13,696
-457
-3% -$7.7K 0.02% 125
2022
Q2 		$280K Buy
14,153
+953
+7% +$25.3K 0.03% 114
2022
Q1 		$418K Buy
13,200
+308
+2% +$8.63K 0.03% 112
2021
Q4 		$288K Buy
12,892
+110
+0.9% +$2.87K 0.02% 118
2021
Q3 		$355K Buy
12,782
+191
+2% +$5.81K 0.02% 120
2021
Q2 		$490K Buy
12,591
+1,060
+9% +$38K 0.03% 110
2021
Q1 		$332K Buy
11,531
+703
+6% +$24K 0.02% 114
2020
Q4 		$287K Buy
+10,828
New +$221K 0.02% 117
2014
Q1 		– Sell
-1,400
Closed -$267K – 117
2013
Q4 		$267K Buy
+1,400
New +$261K 0.02% 116

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sprott Inc's CLB Position: Q2 2023 in Review

Sprott Inc sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 13,359 shares — an estimated $295K sold.

Sprott Inc first reported a position in CLB in Q4 2013 and held it in 11 quarters. The position peaked at $490K in Q2 2021. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Sprott Inc reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Sprott Inc sold 13,359 Core Laboratories shares in Q2 2023, an estimated $295K.
  • Sprott Inc first reported a position in Core Laboratories in Q4 2013 and held it in 11 quarters.
  • Sprott Inc's Core Laboratories position peaked at $490K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Sprott Inc's 13F filing for Q2 2023, filed 14 Aug 2023.